Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (BGMSP)
Market Closed
17 Jul, 20:00
OTC PINK OTC PINK Primary $
1. 34
-0.06
-4.1786%
$
2.4M Market Cap
- P/E Ratio
- Div Yield
1,016 Volume
- Eps
$ 1.4
Previous Close Investors:
Want to track BGMSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (BGMSP) Statistics
Valuation metrics
Market Cap 2.4M
Enterprise value -1.86M
Trailing P/E (ttm) -0.2
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 1.29
Price/Book (mrq) 0.73
Enterprise Value/Revenue -0.9
Enterprise Value/EBITDA 1.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) 467
Price summary
52-Week low 0.3
52-Week high 14
Beta -
50-Day moving average 0.85
200-Day moving average 2.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.6
Trailing annual dividend yield 0.5454%
5-Year annual dividend yield -
Payout ratio -0.03
Dividend Date 1 Feb 2026
Ex-Dividend Date 22 Jan 2026
Last split factor 1:15
Last split Date 7 Jul 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.04%
Operating margin -2.38%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 5.77%
Book value per share (mrq) 1.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
